We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Adient PLC (ADNT - Free Report) reported adjusted earnings per share of 96 cents in first-quarter fiscal 2020, beating the Zacks Consensus Estimate of 31 cents. The figure also came in higher than the year-ago quarter’s 31 cents. This upside mainly resulted from better-than-expected performance in the company’s Americas segment.
During the reported quarter, the company generated net sales of $3,936 million, down from the $4,158 million recorded in first-quarter fiscal 2019. However, the top line surpassed the Zacks Consensus Estimate of $3,840 million.
During the fiscal first quarter, net sales in the Seat Structures & Mechanisms business totaled $2,265 million, up from the $2,201 million reported in first-quarter fiscal 2019. The Interior business generated net sales of $1,978 million, down from the $2067 million witnessed in the prior-year quarter.
Adient currently operates through three reportable segments — Americas, which includes North America and South America; Europe, Middle East, and Africa (“EMEA”); and Asia Pacific/China ("Asia").
In the Americas, the company recorded revenues of $1,859 million, down 3.93% year over year. However, it surpassed the Zacks Consensus Estimate of $1,803 million. Adient generated adjusted EBITDA of $94 million in the fiscal first quarter, indicating a rise from $43 the million recorded in the prior-year period, primarily owing to lower launch costs combined with decreased SG&A costs and low commodity costs.
In EMEA, Adient registered revenues of $1,564 million, down 4.63% year over year. However, it beat the Zacks Consensus Estimate of $1,562 million. Its quarterly adjusted EBITDA was $49 million compared with the prior-year quarter’s $2 million. This upside resulted from lower launch costs, along with decreased SG&A costs and lower commodity costs.
Revenues in the Asia segment were $572 million in the reported quarter compared with the year-earlier quarter’s $650 million. It also missed the Zacks Consensus Estimate of $573 million. The company’s adjusted EBITDA was $177 million compared with the $154 million reported in first-quarter fiscal 2019, mainly aided by an increase in equity income.
Financials
Adient had cash and cash equivalents of $965 million as of Dec 31, 2019 compared with $924 million as of Sep 30 ,2019. As of the same date, net debt amounted to $3,740 million, up from $3,708 billion as of Sep 30, 2019. Debt-to-capital ratio stands at 68.21%. Capital expenditure declined to $91 million in the fiscal first quarter from the $144 million recorded in the prior-year quarter.
Outlook
For 2020, the company has reaffirmed its guidance for consolidated sales at $15.6-$15.8 billion.
It expects adjusted EBITDA of $870-$910 million, up from the prior guidance of $820-$860 million. Capital expenditures are anticipated between $440 million and $460 million, suggesting a rise from the prior estimate of $465-$485 million. Free cash flow is now expected to be positive versus the prior breakeven forecast.
Gentherm has a projected earnings growth rate of 20.60% for the ongoing year. Its shares have gained 7.3% over the past year.
Gentex Corporation has an estimated earnings growth rate of 7.32% for 2020. The company’s shares have appreciated 44.8% in a year’s time.
SPX has an expected earnings growth rate of 8.09% for the current year. The stock has rallied 60.7% in the past year.
Free: Zacks’ Single Best Stock Set to Double
Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.
Image: Bigstock
Adient (ADNT) Tops Q1 Earnings & Sales Estimates, Tweaks View
Adient PLC (ADNT - Free Report) reported adjusted earnings per share of 96 cents in first-quarter fiscal 2020, beating the Zacks Consensus Estimate of 31 cents. The figure also came in higher than the year-ago quarter’s 31 cents. This upside mainly resulted from better-than-expected performance in the company’s Americas segment.
During the reported quarter, the company generated net sales of $3,936 million, down from the $4,158 million recorded in first-quarter fiscal 2019. However, the top line surpassed the Zacks Consensus Estimate of $3,840 million.
During the fiscal first quarter, net sales in the Seat Structures & Mechanisms business totaled $2,265 million, up from the $2,201 million reported in first-quarter fiscal 2019. The Interior business generated net sales of $1,978 million, down from the $2067 million witnessed in the prior-year quarter.
Adient PLC Price, Consensus and EPS Surprise
Adient PLC price-consensus-eps-surprise-chart | Adient PLC Quote
Segment Results
Adient currently operates through three reportable segments — Americas, which includes North America and South America; Europe, Middle East, and Africa (“EMEA”); and Asia Pacific/China ("Asia").
In the Americas, the company recorded revenues of $1,859 million, down 3.93% year over year. However, it surpassed the Zacks Consensus Estimate of $1,803 million. Adient generated adjusted EBITDA of $94 million in the fiscal first quarter, indicating a rise from $43 the million recorded in the prior-year period, primarily owing to lower launch costs combined with decreased SG&A costs and low commodity costs.
In EMEA, Adient registered revenues of $1,564 million, down 4.63% year over year. However, it beat the Zacks Consensus Estimate of $1,562 million. Its quarterly adjusted EBITDA was $49 million compared with the prior-year quarter’s $2 million. This upside resulted from lower launch costs, along with decreased SG&A costs and lower commodity costs.
Revenues in the Asia segment were $572 million in the reported quarter compared with the year-earlier quarter’s $650 million. It also missed the Zacks Consensus Estimate of $573 million. The company’s adjusted EBITDA was $177 million compared with the $154 million reported in first-quarter fiscal 2019, mainly aided by an increase in equity income.
Financials
Adient had cash and cash equivalents of $965 million as of Dec 31, 2019 compared with $924 million as of Sep 30 ,2019. As of the same date, net debt amounted to $3,740 million, up from $3,708 billion as of Sep 30, 2019. Debt-to-capital ratio stands at 68.21%. Capital expenditure declined to $91 million in the fiscal first quarter from the $144 million recorded in the prior-year quarter.
Outlook
For 2020, the company has reaffirmed its guidance for consolidated sales at $15.6-$15.8 billion.
It expects adjusted EBITDA of $870-$910 million, up from the prior guidance of $820-$860 million. Capital expenditures are anticipated between $440 million and $460 million, suggesting a rise from the prior estimate of $465-$485 million. Free cash flow is now expected to be positive versus the prior breakeven forecast.
Zacks Rank & Stocks to Consider
Adient currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Auto-Tires-Trucks sector include Gentherm Inc (THRM - Free Report) , Gentex Corporation (GNTX - Free Report) and SPX Corporation (SPXC - Free Report) . While Gentherm flaunts a Zacks Rank #1 (Strong Buy), Gentex Corporation and SPX carry a Zacks Rank of 2 (Buy), at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Gentherm has a projected earnings growth rate of 20.60% for the ongoing year. Its shares have gained 7.3% over the past year.
Gentex Corporation has an estimated earnings growth rate of 7.32% for 2020. The company’s shares have appreciated 44.8% in a year’s time.
SPX has an expected earnings growth rate of 8.09% for the current year. The stock has rallied 60.7% in the past year.
Free: Zacks’ Single Best Stock Set to Double
Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.
See 5 Stocks Set to Double>>